KOR

e-Article

Isovitexin Is a Direct Inhibitor of Staphylococcus aureus Coagulase
Document Type
Article
Source
Journal of Microbiology and Biotechnology. Oct 31, 2021 31(10):1350
Subject
Isovitexin
coagulase
pneumonia
Staphylococcus aureus
inhibitor
Language
Korean
English
ISSN
1017-7825
Abstract
Staphylococcus aureus (S. aureus) is a major pathogen that causes human pneumonia, leading to significant morbidity and mortality. S. aureus coagulase (Coa) triggers the polymerization of fibrin by activating host prothrombin, which then converts fibrinogen to fibrin and contributes to S. aureus pathogenesis and persistent infection. In our research, we demonstrate that isovitexin, an active traditional Chinese medicine component, can inhibit the coagulase activity of Coa but does not interfere with the growth of S. aureus. Furthermore, we show through thermal shift and fluorescence quenching assays that isovitexin directly binds to Coa. Dynamic simulation and structure-activity relationship analyses suggest that V191 and P268 are key amino acid residues responsible for the binding of isovitexin to Coa. Taken together, these data indicate that isovitexin is a direct Coa inhibitor and a promising candidate for drug development against S. aureus infection.